CVE-2023-37401

CVE-2023-37401 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-942.

Key facts

Description

IBM Aspera Faspex 5.0.0 through 5.0.13.1 uses a cross-domain policy file that includes domains that should not be trusted.

Frequently asked questions

What is CVE-2023-37401?
IBM Aspera Faspex 5.0.0 through 5.0.13.1 uses a cross-domain policy file that includes domains that should not be trusted.
How severe is CVE-2023-37401?
CVE-2023-37401 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2023-37401 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (11th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-37401?
CVE-2023-37401 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-37401?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-37401 have an EU (EUVD) identifier?
Yes. CVE-2023-37401 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-41302.
When was CVE-2023-37401 published?
CVE-2023-37401 was published on 2025-10-09 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-942 vulnerabilities

Browse all CWE-942 vulnerabilities →